美国FDA和FTC:阿片类药物成瘾和健康欺诈

Jeffery L Sumter, Adrieene Goodrich-Doctor
{"title":"美国FDA和FTC:阿片类药物成瘾和健康欺诈","authors":"Jeffery L Sumter, Adrieene Goodrich-Doctor","doi":"10.14293/s2199-1006.1.sor-.pppp8bi.v1","DOIUrl":null,"url":null,"abstract":"Opioid addiction is a serious health epidemic that affects millions of Americans. Opioids are a class of drugs that include: the illegal drug heroin, synthetic opioids (fentanyl), and pain relievers available legally by prescription, such as: oxycodone, hydrocodone, codeine, morphine and others. There are limited drugs approved by the U.S. Food and Drug Administration (FDA) for opioid addition treatment. However, some marketers and distributors are illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal. Selling unapproved products with claims that they can treat opioid addiction and withdrawal is a violation of the Federal Food, Drug, and Cosmetic Act (FD&C) Act, and making unsubstantiated therapeutic claims are also a violation of the Federal Trade Commission Act, which prohibits deceptive advertising.","PeriodicalId":21568,"journal":{"name":"ScienceOpen Posters","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"U.S. FDA and FTC: Opioid Addiction and Health Fraud\",\"authors\":\"Jeffery L Sumter, Adrieene Goodrich-Doctor\",\"doi\":\"10.14293/s2199-1006.1.sor-.pppp8bi.v1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Opioid addiction is a serious health epidemic that affects millions of Americans. Opioids are a class of drugs that include: the illegal drug heroin, synthetic opioids (fentanyl), and pain relievers available legally by prescription, such as: oxycodone, hydrocodone, codeine, morphine and others. There are limited drugs approved by the U.S. Food and Drug Administration (FDA) for opioid addition treatment. However, some marketers and distributors are illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal. Selling unapproved products with claims that they can treat opioid addiction and withdrawal is a violation of the Federal Food, Drug, and Cosmetic Act (FD&C) Act, and making unsubstantiated therapeutic claims are also a violation of the Federal Trade Commission Act, which prohibits deceptive advertising.\",\"PeriodicalId\":21568,\"journal\":{\"name\":\"ScienceOpen Posters\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ScienceOpen Posters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14293/s2199-1006.1.sor-.pppp8bi.v1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ScienceOpen Posters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14293/s2199-1006.1.sor-.pppp8bi.v1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

阿片类药物成瘾是一种严重的健康流行病,影响着数百万美国人。阿片类药物是一类药物,包括:非法药物海洛因、合成阿片类药物(芬太尼)和合法处方止痛药,如:羟考酮、氢可酮、可待因、吗啡等。美国食品和药物管理局(FDA)批准的用于阿片类药物附加治疗的药物有限。然而,一些营销商和分销商非法销售未经证实的产品,声称它们能够帮助治疗阿片类药物成瘾和戒断。销售声称可以治疗阿片类药物成瘾和戒断的未经批准的产品违反了《联邦食品、药品和化妆品法案》(FD&C),而制作未经证实的治疗声明也违反了《联邦贸易委员会法案》,该法案禁止欺骗性广告。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
U.S. FDA and FTC: Opioid Addiction and Health Fraud
Opioid addiction is a serious health epidemic that affects millions of Americans. Opioids are a class of drugs that include: the illegal drug heroin, synthetic opioids (fentanyl), and pain relievers available legally by prescription, such as: oxycodone, hydrocodone, codeine, morphine and others. There are limited drugs approved by the U.S. Food and Drug Administration (FDA) for opioid addition treatment. However, some marketers and distributors are illegally marketing products with unproven claims about their ability to help in the treatment of opioid addiction and withdrawal. Selling unapproved products with claims that they can treat opioid addiction and withdrawal is a violation of the Federal Food, Drug, and Cosmetic Act (FD&C) Act, and making unsubstantiated therapeutic claims are also a violation of the Federal Trade Commission Act, which prohibits deceptive advertising.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信